Global Digital Therapy Market Research Report (2021-2026)

DUBLIN, December 21, 2021 / PRNewswire / – The “Digital Therapy Market Research Report by Indication, Component, Distribution, and Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” the report was added to offer.

Research and Markets logo

The global digital therapy market size has been estimated to be $ 2,472.67 million in 2020, is expected to reach $ 3,048.70 million in 2021, and is expected to grow at a CAGR of 23.63% reaching $ 8,830.68 million by 2026.

Market statistics

The report provides market size and forecast in five major currencies: USD, EUR GBP, JPY, and AUD. It helps organizational leaders make better decisions when currency data is readily available. In this report, the years 2018 and 2019 are considered as historical years, 2020 as the base year, 2021 as the estimated year and the years 2022 to 2026 are considered as the forecast period.

Competitive strategic window

The Competitive Strategy Window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for suppliers to adopt successive merger and acquisition strategies, geographic expansion, research and development, and new product introduction strategies to continue the expansion and growth of the business during a forecast period.

FPNV positioning matrix

The FPNV Positioning Matrix assesses and ranks vendors in the digital therapy market based on business strategy (company growth, industry coverage, financial viability, and channel support) and product satisfaction ( value for money, ease of use, product features, and customer support) that helps businesses make better decisions and better understand the competitive landscape.

Market share analysis

The market share analysis offers the analysis of the suppliers considering their contribution to the overall market. It provides the idea of ​​its revenue generation in the overall market compared to other space providers. It provides insight into the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of the suppliers for the base year. It reveals the characteristics of the market in terms of traits of accumulation, fragmentation, dominance and fusion.

Company usability profiles

The report deeply explores the significant recent developments of leading vendors and innovation profiles in the global digital therapy market including 2morrow Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, BigHealth, Canary Health Inc., Click Therapeutics, Cognoa, Ginger.Io, Inc., Happify, Kaia Health, Lark Technologies, Livongo Health, Inc., Mango Health Inc., Mindstrong Health, Noom Inc., Omada Health, Inc., A decrease, Pear Therapeutics, Propeller Health, Proteus Digital Health, Inc., Twine Health, Inc., Vitra Health, Welldoc, Inc. and Wellthy Therapeutics.

The report provides information on the following pointers:
1. Market penetration: provides comprehensive information on the market offered by major players
2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration into mature market segments.
3. Market diversification: provides detailed information on new product launches, untapped geographies, recent developments and investments
4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape and manufacturing capabilities of key players
5. Product Development and Innovation: Provides intelligent information on future technologies, R&D activities and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast for the global digital therapy market?
2. What are the inhibitory factors and impact of COVID-19 shaping the global digital therapy market during the forecast period?
3. What are the products / segments / applications / areas to invest in during the forecast period in the global digital therapy market?
4. What is the competitive strategic window for opportunities in the global digital therapy market?
5. What are the technological trends and regulatory frameworks in the global digital therapy market?
6. What is the market share of the major vendors in the global digital therapy market?
7. What strategic fashions and movements are considered appropriate to enter the global digital therapy market?

Main topics covered:

1. Preface

2. Research methodology

3. Executive summary

4. Market overview
4.1. introduction
4.2. Cumulative impact of COVID-19

5. Market dynamics
5.1. introduction
5.2. Conductors
5.2.1. Growing incidence of preventive chronic diseases
5.2.2. Control of health costs with a focus on preventive health care
5.2.3. Adoption of smartphones and tablets coupled with health applications
5.3. Constraints
5.3.1. Limited awareness of digital therapeutics in developing economies
5.4. Opportunities
5.4.1. Huge undiagnosed and untreated population base
5.4.2. Technology to discover therapeutic areas
5.5. Challenges
5.5.1. Data privacy and security concerns

6. Digital Therapy Market, By Indication
6.1. introduction
6.2. Heart disease
6.3. Central nervous system disorder
6.4. Chronic respiratory disease
6.5. Diabetes
6.6. Adherence to medication
6.7. Musculoskeletal disorder
6.8. Obesity
6.9. Prediabetes
6.10. Smoking cessation

7. Digital Therapy Market, By Component
7.1. introduction
7.2. Devices
7.3. Software

8. Digital Therapy Market, By Distribution
8.1. introduction
8.2. B2B
8.2.1. Employer
8.2.2. Payer
8.2.3. Pharmaceutical company
8.2.4. Provider
8.3. B2C
8.3.1. Caregiver
8.3.2. Patient

9. Americas Digital Therapy Market
9.1. introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Digital Therapy Market
10.1. introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Digital therapy market in Africa
11.1. introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. UK

12. Competitive landscape
12.1. FPNV positioning matrix
12.1.1. Quadrants
12.1.2. Business strategy
12.1.3. Product satisfaction
12.2. Market ranking analysis
12.3. Market share analysis, by key player
12.4. Competitive scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, collaboration and partnership
12.4.3. New product launch and improvement
12.4.4. Investment and financing
12.4.5. Awards, recognition and expansion

13. Company usability profiles
13.1. 2morrow Inc.
13.2. Akili Interactive Laboratories
13.3. Ayogo Health Inc.
13.4. Best therapies
13.5. GreatHealth
13.6. Canary Health Inc.
13.7. Click on Therapeutic
13.8. Cognoa
13.9. Ginger.Io, Inc.
13.10. Happy
13.11. Kaia Health
13.12. Lark Technologies
13.13. Livongo Health, Inc.
13.14. Mango Health Inc.
13.15. Mental Health
13.16. Noom Inc.
13.17. Omada Health, Inc.
13.18. A decrease
13.19. Therapeutic Pear
13.20. Propeller health
13.21. Proteus Digital Health, Inc.
13.22. Twine Health, Inc.
13.23. Vitra Health
13.24. Welldoc, Inc.
13.25. Therapeutic well-being

14. Annex

For more information on this report, visit

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716



Show original content:—by-indication-component-distribution-and-region-301448841.html

SOURCE Research and Markets

About Michael Bill

Check Also

Orphan Indication Treatment Market Growth Prospects: 2022, Regional Demand, Qualitative Analysis and Dynamic Innovations | Bristol-Myers Squibb, Roche, Novartis

The latest report published by SMI provides a comprehensive assessment of “Orphan Indications Treatment Market …